Company Filing History:

8 out of 523

Pharmacia & Upjohn Company

Pharmacia Corporation

patents

5. 3 out of 832,680

Other

patents

Years Active: 1992-2005

Loading Chart...

18 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 6861438 - Antiviral agents (2005-03-01),

2. 6852731 - Antiviral compounds (2005-02-08),

3. 6624160 - 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents (2003-09-23),

4. 6458788 - 4-hydroxycinnoline-3-carboxyamides as antiviral agents (2002-10-01),

5. 6410585 - Inhibitors of protein tyrosine phosphatase (2002-06-25),

6. 6353023 - Inhibitors of protein tyrosine phosphatase (2002-03-05),

7. 6329545 - Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus (2001-12-11),

8. 6274580 - Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus (2001-08-14),

9. 6184216 - Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus (2001-02-06),

10. 6177453 - Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus (2001-01-23),

11. 6166080 - Aminoquanidine carboxylates for the treatment of obesity (2000-12-26),

12. 5994577 - Aminoguanidine carboxylates for the treatment of non-insulin-dependent (1999-11-30),

13. 5955617 - Aminoguanidine carboxylate lactams for the treatment of (1999-09-21),

14. 5723476 - 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus (1998-03-03),

15. 5597816 - Pyrazoloazepino substituted oximes useful as anti-atherosclerosis and (1997-01-28),

Title: Scott D Larsen: Innovator in Antiviral Compounds

Introduction

Scott D Larsen is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of antiviral agents, holding a total of 18 patents. His work focuses on developing compounds that can effectively treat herpesvirus infections.

Latest Patents

Among his latest patents, Larsen has developed innovative antiviral agents. One of his inventions provides a compound of formula I, wherein G, R, and R have specific values defined in the specification, or a pharmaceutically acceptable salt thereof. This invention also includes processes and intermediates useful for preparing such compounds or salts, along with methods for treating herpesvirus infections using these compounds. Another patent focuses on antiviral compounds, similarly providing a compound of formula I with defined values, aimed at preventing or treating herpesvirus infections.

Career Highlights

Scott D Larsen has had a distinguished career, working with prominent companies such as Pharmacia & Upjohn Company and The Upjohn Company. His experience in these organizations has contributed to his expertise in the development of pharmaceutical innovations.

Collaborations

Throughout his career, Larsen has collaborated with notable colleagues, including Paul D May and Valerie Ann Vaillancourt. These collaborations have likely enriched his research and development efforts in the field of antiviral compounds.

Conclusion

Scott D Larsen is a prominent inventor whose work in antiviral agents has the potential to impact the treatment of herpesvirus infections significantly. His contributions to the field are marked by a strong portfolio of patents and collaborations with esteemed colleagues.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.